MicroRNA-21, up-regulated by arsenite, directs the epithelial-mesenchymal transition and enhances the invasive potential of transformed human bronchial epithelial cells by targeting PDCD4

Toxicology Letters

Volumn 232, Issue 1, 2015, Pages 301-309

  Luo, Fei ^a   Ji, Jie ^a   Liu, Yi ^a   Xu, Yuan ^a   Zheng, Gang ^b   Jing, Jinfei ^b   Wang, Bairu ^a   Xu, Wenchao ^a   Shi, Le ^a   Lu, Xiaolin ^a   Liu, Qizhan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arsenite; Carcinogenesis; Epithelial mesenchymal transition (EMT); MiRNA 21

Indexed keywords

ARSENIC TRIOXIDE; MEMBRANE PROTEIN; MICRORNA 21; PROGRAMMED CELL DEATH 4; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; ARSENITE SODIUM; ARSENOUS ACID DERIVATIVE; MICRORNA; MIRN21 MICRORNA, HUMAN; NUCLEAR PROTEIN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN; SODIUM DERIVATIVE; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN BRONCHIAL EPITHELIAL CELL; HUMAN CELL; LUNG CARCINOGENESIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION; BRONCHUS; CELL MOTION; CELL TRANSFORMATION; CHEMICALLY INDUCED; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TRANSFORMED CELL LINE;

APOPTOSIS REGULATORY PROTEINS; ARSENITES; BRONCHI; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LUNG NEOPLASMS; MICRORNAS; NUCLEAR PROTEINS; RNA INTERFERENCE; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SODIUM COMPOUNDS; TIME FACTORS; TRANSFECTION; TWIST-RELATED PROTEIN 1; UP-REGULATION;

EID: 84911386194     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.11.001     Document Type: Article

References (45)

1. Bao B., Wang Z., Ali S., Kong D., Li Y., Ahmad A., Banerjee S., Azmi A.S., Miele L., Sarkar F.H. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett. 2011, 307:26-36.
2. Bornachea O., Santos M., Martinez-Cruz A.B., Garcia-Escudero R., Duenas M., Costa C., Segrelles C., Lorz C., Buitrago A., Saiz-Ladera C., Agirre X., Grande T., Paradela B., Maraver A., Ariza J.M., Prosper F., Serrano M., Sanchez-Cespedes M., Paramio J.M. EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours. Sci. Rep. 2012, 2:434.
3. Cantor K.P., Lubin J.H. Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol. Appl. Pharmacol. 2007, 222:252-257.
4. Carinci F., Lo Muzio L., Piattelli A., Rubini C., Chiesa F., Ionna F., Palmieri A., Maiorano E., Pastore A., Laino G., Dolci M., Pezzetti F. Potential markers of tongue tumor progression selected by cDNA microarray. Int. J. Immunopathol. Pharmacol. 2005, 18:513-524.
5. Chen C.L., Hsu L.I., Chiou H.Y., Hsueh Y.M., Chen S.Y., Wu M.M., Chen C.J. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. Jama 2004, 292:2984-2990.
6. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 2007, 6:60.
7. Farazi T.A., Horlings H.M., Ten Hoeve J.J., Mihailovic A., Halfwerk H., Morozov P., Brown M., Hafner M., Reyal F., van Kouwenhove M., Kreike B., Sie D., Hovestadt V., Wessels L.F., van de Vijver M.J., Tuschl T. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 2011, 71:4443-4453.
8. Goke R., Barth P., Schmidt A., Samans B., Lankat-Buttgereit B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am. J. Physiol. 2004, 287:C1541-1546.
9. Han M., Liu M., Wang Y., Chen X., Xu J., Sun Y., Zhao L., Qu H., Fan Y., Wu C. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PloS One 2012, 7:e39520.
10. Herranz N., Pasini D., Diaz V.M., Franci C., Gutierrez A., Dave N., Escriva M., Hernandez-Munoz I., Di Croce L., Helin K., Garcia de Herreros A., Peiro S. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol. Cell. Biol. 2008, 28:4772-4781.
11. Hou Z., Peng H., Ayyanathan K., Yan K.P., Langer E.M., Longmore G.D., Rauscher F.J. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol. Cell. Biol. 2008, 28:3198-3207.
12. Huang C., Ke Q., Costa M., Shi X. Molecular mechanisms of arsenic carcinogenesis. Mol. Cell. Biochem. 2004, 255:57-66.
13. Huang T.H., Wu F., Loeb G.B., Hsu R., Heidersbach A., Brincat A., Horiuchi D., Lebbink R.J., Mo Y.Y., Goga A., McManus M.T. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J. Biol. Chem. 2009, 284:18515-18524.
14. Jansen A.P., Camalier C.E., Colburn N.H. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res. 2005, 65:6034-6041.
15. Kumagai Y., Sumi D. Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Ann. Rev. Pharmacol. Toxicol. 2007, 47:243-262.
16. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science (New York, NY) 2001, 294:853-858.
17. Lankat-Buttgereit B., Gregel C., Knolle A., Hasilik A., Arnold R., Goke R. Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol. Cell. Endocrinol. 2004, 214:149-153.
18. Lee T.I., Johnstone S.E., Young R.A. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat. Prot. 2006, 1:729-748.
19. Lee J.H., Voortman J., Dingemans A.M., Voeller D.M., Pham T., Wang Y., Giaccone G. MicroRNA expression and clinical outcome of small cell lung cancer. PloS One 2011, 6:e21300.
20. Leupold J.H., Yang H.S., Colburn N.H., Asangani I., Post S., Allgayer H. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 2007, 26:4550-4562.
21. Li T., Li D., Sha J., Sun P., Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem. Biophys. Res. Commun. 2009, 383:280-285.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
23. Luo F., Xu Y., Ling M., Zhao Y., Xu W., Liang X., Jiang R., Wang B., Bian Q., Liu Q. Arsenite evokes IL-6 secretion, autocrine regulation of STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation of human bronchial epithelial cells. Toxicol. Appl. Pharmacol. 2013, 273:27-34.
24. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
25. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
26. Peinado H., Portillo F., Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 2004, 48:365-375.
27. Pezzolesi M.G., Platzer P., Waite K.A., Eng C. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am. J. Hum. Gen. 2008, 82:1141-1149.
28. Rask L., Balslev E., Jorgensen S., Eriksen J., Flyger H., Moller S., Hogdall E., Litman T., Nielsen B.S. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. Apmis 2011, 119:663-673.
29. Shen L., Ling M., Li Y., Xu Y., Zhou Y., Ye J., Pang Y., Zhao Y., Jiang R., Zhang J., Liu Q. Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation. PloS One 2013, 8:e57652.
30. Shih J.Y., Yang P.C. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011, 32:1299-1304.
31. Shiota M., Izumi H., Tanimoto A., Takahashi M., Miyamoto N., Kashiwagi E., Kidani A., Hirano G., Masubuchi D., Fukunaka Y., Yasuniwa Y., Naito S., Nishizawa S., Sasaguri Y., Kohno K. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Res. 2009, 69:3148-3156.
32. Shyu A.B., Wilkinson M.F., van Hoof A. Messenger RNA regulation: to translate or to degrade. EMBO J. 2008, 27:471-481.
33. Si M.L., Zhu S., Wu H., Lu Z., Wu F., Mo Y.Y. miR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
34. Song L.B., Li J., Liao W.T., Feng Y., Yu C.P., Hu L.J., Kong Q.L., Xu L.H., Zhang X., Liu W.L., Li M.Z., Zhang L., Kang T.B., Fu L.W., Huang W.L., Xia Y.F., Tsao S.W., Li M., Band V., Band H., Shi Q.H., Zeng Y.X., Zeng M.S. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J. Clin. Invest. 2009, 119:3626-3636.
35. Tapio S., Grosche B. Arsenic in the aetiology of cancer. Mutat. Res. 2006, 612:215-246.
36. Way T.D., Huang J.T., Chou C.H., Huang C.H., Yang M.H., Ho C.T. Emodin represses TWIST1-induced epithelial?mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the beta-catenin and Akt pathways. Eur. J. Cancer 2013, 50:366-378.
37. Weinberg R.A. Mechanisms of malignant progression. Carcinogenesis 2008, 29:1092-1095.
38. World Health Organization Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. IARC monographs on the evaluation of carcinogenic risks to humans. Int. Agency Res. Cancer 2004, 84:269-477.
39. Xu Y., Li Y., Pang Y., Ling M., Shen L., Yang X., Zhang J., Zhou J., Wang X., Liu Q. EMT and stem cell-like properties associated with HIF-2alpha are involved in arsenite-induced transformation of human bronchial epithelial cells. PloS One 2012, 7:e37765.
40. Yan L.X., Huang X.F., Shao Q., Huang M.Y., Deng L., Wu Q.L., Zeng Y.X., Shao J.Y. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA (New York, NY) 2008, 14:2348-2360.
41. Yang H.S., Matthews C.P., Clair T., Wang Q., Baker A.R., Li C.C., Tan T.H., Colburn N.H. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol. Cell. Biol. 2006, 26:1297-1306.
42. Yang M.H., Hsu D.S., Wang H.W., Wang H.J., Lan H.Y., Yang W.H., Huang C.H., Kao S.Y., Tzeng C.H., Tai S.K., Chang S.Y., Lee O.K., Wu K.J. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol. 2010, 12:982-992.
43. Yang C.H., Yue J., Pfeffer S.R., Handorf C.R., Pfeffer L.M. MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J. Biol. Chem. 2011, 286:39172-39178.
44. Zavadil J., Narasimhan M., Blumenberg M., Schneider R.J. Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 2007, 185:157-161.
45. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.